Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients
Clinical trial NCT00936221 · COMPLETED
Trial details
- NCT number
- NCT00936221
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2011-11-01
- Enrollment
- 385
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.